C9460 HCPCS code: Injection, cangrelor, 1 mg
C9460 is the HCPCS Level II code for injection, cangrelor, 1 mg. Its Medicare coverage code is D (Special coverage instructions apply): Medicare covers it when its national or local coverage criteria are met. The NCCI unit limit is 100 per day on outpatient hospital claims.
Code details
| Field | Value |
|---|---|
| Section | C codes — Outpatient PPS (hospital outpatient temporary codes) |
| Coverage code | D — Special coverage instructions apply |
| Pricing indicator | 53 |
| BETOS category | O1E — Other drugs |
| Added | 2016-01-01 |
| Last action effective | 2016-01-01 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| outpatient hospital claims | 100 | Prescribing Information |
| practitioner claims | 1 | Clinical: CMS Workgroup |
What changed for C9460
- 2016-01-01: C9460 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code C9460?
C9460 is the HCPCS Level II code for injection, cangrelor, 1 mg. Short descriptor: "Injection, cangrelor".
Does Medicare cover C9460?
Coverage code D — Special coverage instructions apply. Medicare covers it when its national or local coverage criteria are met.
How many units of C9460 can be billed per day?
100 on outpatient hospital claims; 1 on practitioner claims (NCCI medically unlikely edits).
Related C94 codes
- C9407 — Iodine i-131 iobenguane, diagnostic, 1 millicurie
- C9408 — Iodine i-131 iobenguane, therapeutic, 1 millicurie
- C9441 — Injection, ferric carboxymaltose, 1 mg
- C9442 — Injection, belinostat, 10 mg
- C9443 — Injection, dalbavancin, 10 mg
- C9444 — Injection, oritavancin, 10 mg
- C9445 — Injection, c-1 esterase inhibitor (recombinant), ruconest, 10 units
- C9446 — Injection, tedizolid phosphate, 1 mg
- C9447 — Injection, phenylephrine and ketorolac, 4 ml vial
- C9448 — Netupitant 300 mg and palonosetron 0.5 mg, oral
- C9449 — Injection, blinatumomab, 1 mcg
- C9450 — Injection, fluocinolone acetonide intravitreal implant, 0.01 mg
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under C9460
- Watch C9460 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for C9460
Sources: CMS HCPCS Level II release October 2026; CMS DMEPOS fee schedule; CMS NCCI MUE tables; CMS Medicare utilization (physician and DME supplier files); CMS Medicare Coverage Database articles. Fees are Medicare allowables, not commercial rates. Not billing or legal advice.